Loading clinical trials...
Loading clinical trials...
Virtual Reality in Chronic Obstructive Pulmonary Disease: Randomized Contolled Trial
In addition to conventional pulmonary rehabilitation, virtual reality will be applied during the hospitalization period of individuals hospitalized for COPD exacerbation. It is aimed to get more efficiency from the interventions in this short time.
Subjects with COPD exacerbation will be divided two groups. Group-1 will exercise with a bicycle ergometer until fatigue in addition to pulmonary rehabilitation. Group-2 will do the same exercises. Subjects in Group-2 will use virtual reality simulation, which is designed as cycling in the forest while cycling. Treatment will continue until discharge. CAT score, mMRC dyspnea score, hospital anxiety and depression score and London chest daily living activity score will be examined before and after treatment.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Pamukkale University
Denizli, Pamukkale, Turkey (Türkiye)
Start Date
June 1, 2022
Primary Completion Date
April 10, 2024
Completion Date
April 22, 2024
Last Updated
April 2, 2024
50
ESTIMATED participants
virtual reality
DEVICE
conventional pulmonary rehabilitation
OTHER
Lead Sponsor
Pamukkale University
NCT07430943
NCT07351929
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07195838